Literature DB >> 11177566

Guidance for human somatic cell therapy and gene therapy.

.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2001        PMID: 11177566     DOI: 10.1089/10430340150218431

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  22 in total

1.  Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells.

Authors:  Steven A Feldman; Stephanie L Goff; Hui Xu; Mary A Black; James N Kochenderfer; Laura A Johnson; James C Yang; Qiong Wang; Maria R Parkhurst; Scott Cross; Richard A Morgan; Kenneth Cornetta; Steven A Rosenberg
Journal:  Hum Gene Ther       Date:  2010-12-12       Impact factor: 5.695

2.  A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.

Authors:  Qingfu Xu; Maria T Arevalo; Michael E Pichichero; Mingtao Zeng
Journal:  Cytotechnology       Date:  2006-11-18       Impact factor: 2.058

Review 3.  Implications of clinical trial design on sample size requirements.

Authors:  Andrew C Leon
Journal:  Schizophr Bull       Date:  2008-05-09       Impact factor: 9.306

Review 4.  Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy.

Authors:  Shen Cheng; Susheel Kumar Nethi; Sneha Rathi; Buddhadev Layek; Swayam Prabha
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

5.  Clinical research skills development program in cell-based regenerative medicine.

Authors:  Ivonne Hernandez Schulman; Viky Suncion; Vasileios Karantalis; Wayne Balkan; Joshua M Hare
Journal:  Stem Cells Transl Med       Date:  2014-12-29       Impact factor: 6.940

6.  Efficacy and tolerability of an argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases.

Authors:  S Krasovec; A Ornani; M Oleastro; S Rosenzweig; A Roy; L Perez; G Campos; N Marín; A Martinez; C Mahieu; M J Manfredi; A Sisti; M Zelazko
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

7.  A rational mouse model to detect on-target, off-tumor CAR T cell toxicity.

Authors:  Mauro Castellarin; Caroline Sands; Tong Da; John Scholler; Kathleen Graham; Elizabeth Buza; Joseph A Fraietta; Yangbing Zhao; Carl H June
Journal:  JCI Insight       Date:  2020-07-23

8.  Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

Authors:  J C M van der Loo; W P Swaney; E Grassman; A Terwilliger; T Higashimoto; A Schambach; C Baum; A J Thrasher; D A Williams; D L Nordling; L Reeves; P Malik
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

9.  Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.

Authors:  Drew S Cunningham; Richard R Koepsel; Mohammad M Ataai; Michael M Domach
Journal:  Microb Cell Fact       Date:  2009-05-22       Impact factor: 5.328

10.  Safe composition levels of transgenic crops assessed via a clinical medicine model.

Authors:  Rod A Herman; Peter N Scherer; Amy M Phillips; Nicholas P Storer; Mark Krieger
Journal:  Biotechnol J       Date:  2010-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.